Reuters logo
BRIEF-CSL to acquire majority stake in Chinese plasma fractionator
June 12, 2017 / 10:50 PM / 6 months ago

BRIEF-CSL to acquire majority stake in Chinese plasma fractionator

June 13 (Reuters) - CSL Ltd

* ‍CSL to acquire an 80 per cent stake in Wuhan Zhong Yuan Rui De Biologics for US$352 million​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below